Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

Loading...
Loading...
Below are the top drugs-generic stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Akorn
AKRX
is 18.99%. Akorn's revenue for the same period is $227.26 million. The trailing-twelve-month return on equity at Hi Tech Pharmacal Co
HITK
is 18.38%. Hi Tech Pharmacal's operating margin for the same period is 24.58%. The trailing-twelve-month return on equity at Salix Pharmaceuticals
SLXP
is 15.84%. Salix Pharmaceuticals had $775.90 million in total cash for the latest quarter. The trailing-twelve-month return on equity at Mylan
MYL
is 14.65%. Mylan's PEG ratio is 0.72.
Posted In: Trading IdeasDrugs-Generic Industryhighest ROENASDAQ
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...